Ranger Investment Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-690
Closed -$26K – 109
2019
Q4
$26K Hold
690
– – ﹤0.01% 100
2019
Q3
$32K Buy
690
+330
+92% +$15.3K ﹤0.01% 97
2019
Q2
$19K Hold
360
– – ﹤0.01% 102
2019
Q1
$25K Hold
360
– – ﹤0.01% 97
2018
Q4
$21K Hold
360
– – ﹤0.01% 102
2018
Q3
$42K Hold
360
– – ﹤0.01% 93
2018
Q2
$45K Hold
360
– – ﹤0.01% 112
2018
Q1
$39K Hold
360
– – ﹤0.01% 112
2017
Q4
$39K Hold
360
– – ﹤0.01% 117
2017
Q3
$36K Hold
360
– – ﹤0.01% 116
2017
Q2
$36K Hold
360
– – ﹤0.01% 122
2017
Q1
$42K Sell
360
-85
-19% -$9.88K ﹤0.01% 129
2016
Q4
$53K Sell
445
-3,240
-88% -$359K ﹤0.01% 123
2016
Q3
$414K Buy
3,685
+1,120
+44% +$129K 0.03% 118
2016
Q2
$318K Buy
2,565
+20
+0.8% +$2.41K 0.02% 118
2016
Q1
$286K Buy
+2,545
New +$264K 0.02% 116

Other funds holding CLB

Ranger Investment Management's CLB Position: Q1 2020 in Review

Ranger Investment Management sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 690 shares — an estimated $26K sold.

Ranger Investment Management first reported a position in CLB in Q1 2016 and held it in 16 quarters. The position peaked at $414K in Q3 2016. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

  • Ranger Investment Management reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
  • Ranger Investment Management sold 690 Core Laboratories shares in Q1 2020, an estimated $26K.
  • Ranger Investment Management first reported a position in Core Laboratories in Q1 2016 and held it in 16 quarters.
  • Ranger Investment Management's Core Laboratories position peaked at $414K in Q3 2016.
  • 207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on Ranger Investment Management's 13F filing for Q1 2020, filed 15 May 2020.